1 Healthcare Stock for Long-Term Investors and 2 We Turn Down

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destocking have persisted in the wake of COVID-19, limiting growth. This has capped returns as the industry’s six-month gain of 7.7% has lagged the S&P 500’s 9.3% climb.